Healthcare Artificial Intelligence – the market is all set to cruise to a high altitude following plans by major healthcare players to employ Artificial intelligence into their platforms.

"August 2023, Market Research Future has published a Report on the Global Healthcare Artificial Intelligence Market."

Market Research Future (MRFR) has published a cooked research report on the “Global Artificial Intelligence in Healthcare Market” that contains information from 2023 to 2032. 

Healthcare Artificial Intelligence Market Highlights

The Global Healthcare Artificial Intelligence Market is accounted to register a CAGR of 51.90% during the forecast period and is estimated to reach USD 21.52 Billion by 2032.

The Global Artificial Intelligence (AI) in Healthcare Market refers to the overall market encompassing the use and adoption of artificial intelligence technologies and applications in the healthcare industry worldwide. This market combines AI technology with healthcare-related data to provide solutions that can enhance medical diagnosis, treatment, drug development, patient care, and administrative processes.

The Global AI in Healthcare Market is driven by factors such as a growing demand for advanced healthcare technologies, an increase in the volume of healthcare data, the need for improved patient outcomes, rising healthcare costs, and advancements in AI research and development.

Key Players

MRFR recognizes the following companies as the key players in the Global Artificial Intelligence in Healthcare Market— Google, Medtronic, Amazon Web Services, Johnson & Johnson, General Electric Company, General Vision, CloudmedX, Oncora Medical, Enlitic, Lunit, and Cota.

Segment Analysis

The Global Artificial Intelligence in Healthcare Market has been segmented based on technology, application and end user.

On the basis of technology, the market is segmented into machine learning, querying method and natural language processing. Machine learning is helpful for healthcare applications like detecting early indications of sickness or optimizing drug discovery through imaging data because it enables computers to learn from enormous volumes of data rather than following a specified set of instructions.

Based on application, the market has been segmented into robot-assisted surgery, virtual nursing assistant, dosage error reduction and clinical trial. AI-based pathology tools have become more popular due to the success of AI-based diagnostics tools.

Based on end user, the market has been segmented into pharmaceutical & biotechnology companies, hospital & diagnostic centers and academic & research laboratories. This category is expanding due to the rising use of new technologies in these environments and the growing level of industry-wide cooperation.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Healthcare Artificial Intelligence Market Research Report

Regional Analysis

The Global Artificial Intelligence in Healthcare Market, based on region, has been divided into the North America, Europe, Asia-Pacific, and Rest of the World. North America consists of US and Canada. The Europe Global Artificial Intelligence in Healthcare Market comprises of Germany, France, the UK, Italy, Spain, and the rest of Europe. The Global Artificial Intelligence in Healthcare Market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the World Global Artificial Intelligence in Healthcare Market comprises of Middle East, Africa, and Latin America.

North America, particularly the United States, has been at the forefront of AI adoption in healthcare. The region benefits from a robust healthcare infrastructure, a well-established technology industry, and significant investments in AI research and development.

European countries have also been proactive in adopting AI in healthcare, with a focus on applications such as medical imaging, drug discovery, and patient data analytics.

The Asia-Pacific region has emerged as a promising market for AI in healthcare due to its large and growing population, increasing healthcare demands, and rising technological advancements.

Furthermore, the rest of the world's Global Artificial Intelligence in Healthcare Market is divided into the Middle East, Africa, and Latin America. The Latin American region has shown a growing interest in AI adoption in healthcare, driven by increasing awareness of AI's potential benefits and improvements in healthcare infrastructure.

Key Findings of the Study

• The Global Artificial Intelligence in Healthcare Market is expected to reach USD 21.52 Billion by 2032, at a CAGR of 51.90% during the forecast period.


• North America, particularly the United States, has been at the forefront of AI adoption in healthcare. The region benefits from a robust healthcare infrastructure, a well-established technology industry, and significant investments in AI research and development.


• Based on application, the market has been segmented into robot-assisted surgery, reduction and clinical trial to holding the largest market in 2022.


• Google, Medtronic, Amazon Web Services, Johnson & Johnson, General Electric Company, General Vision, CloudmedX, Oncora Medical, Enlitic, Lunit and Cota.